Coronary heart disease in Diabetics

	2016 ADA Guideline Recommendations
Types of Diabetes Mellitus
Main Diabetes Page
Diabetes type I
Diabetes type II
Gestational Diabetes Mellitus
2016 ADA Standard of Medical Care Guideline Recommendations
Strategies for Improving Care
Classification and Diagnosis of Diabetes
Foundations of Care and Comprehensive Medical Evaluation Diabetes Self-Management, Education, and Support Nutritional Therapy
Prevention or Delay of Type II Diabetes
Glycemic Targets
Obesity Management for Treatment of Type II Diabetes
Approaches to Glycemic Treatment
Cardiovascular Disease and Risk Management Hypertension and Blood Pressure Control Lipid Management Antiplatelet Agents Coronary Heart Disease
Microvascular Complications and Foot Care Diabetic Kidney Disease Diabetic Retinopathy Diabetic Neuropathy Diabetic Footcare
Older Adults with Diabetes
Children and Adolescents with Diabetes Management of Cardiovascular Risk Factors in Children and Adolescents with Diabetes Microvascular Complications in Children and Adolescents with Diabetes
Management of Diabetes in Pregnancy
Diabetes Care in the Hospital Setting

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shivani Chaparala M.B.B.S [2]; Seyedmahdi Pahlavani, M.D. [3]; Tarek Nafee, M.D. [4]

2016 ADA Standards of Medical Care in Diabetes Guidelines

"1.In asymptomatic patients, routine screening for coronary artery dis- ease is not recommended as it does not improve outcomes as long as atherosclerotic cardiovascular disease risk factors are treated (Level of Evidence: A)"
"2. Consider investigations for coronary artery disease in the presence of any of the following: atypical cardiac symptoms (e.g., unexplained dyspnea, chest discomfort); signs or symptoms of associated vascular disease including carotid bruits, transient ischemic attack, stroke, claudication, or peripheral arterial disease; or electrocardiogram abnormalities (e.g., Q waves) (Level of Evidence: E)"

"1.In patients with known atherosclerotic cardiovascular disease, use aspirin and statin therapy (if not contraindicated) "(Level of Evidence: A)" and consider ACE inhibitor therapy. (Level of Evidence: C) to reduce the risk of cardiovascular events."
"2.In patients with prior myocardial infarction, b-blockers should be continued for at least 2 years after the event (Level of Evidence: B)"
"3.In patients with symptomatic heart failure, thiazolidinedione treatment should not be used (Level of Evidence: A)"
"4.In patients with type 2 diabetes with stable congestive heart failure, met- formin may be used if renal function is normal but should be avoided in unstable or hospitalized patients with congestive heart failure (Level of Evidence: B)"